Skip to Main Content

Paper Details

Assessing the cost burden of United States FDA-mandated post-approval studies for medical devices.
J Health Care Finance
10
2016
PAS
Costs and Cost Analysis, Device Approval, Equipment Design, Humans, Safety, United States, United States Food and Drug Administration
Author NameAffiliation
Neil J Wimmer
Susan RobbinsComparative Effectiveness Research Institute and Department of Cardiovascular Medicine, Lahey Clinic Foundation
Henry SsemagandaComparative Effectiveness Research Institute and Department of Cardiovascular Medicine, Lahey Clinic Foundation
Erin YangComparative Effectiveness Research Institute and Department of Cardiovascular Medicine, Lahey Clinic Foundation
Sharon-Lise T NormandHarvard Medical School, Harvard T.H. Chan School of Public Health
Michael MathenyGeriatrics Research Education and Clinical Center (GRECC), Tennessee Valley Healthcare System, TN Vanderbilt University School of Medicine
Michael E MathenyGeriatrics Research Education and Clinical Center (GRECC), Tennessee Valley Healthcare System, TN Vanderbilt University School of Medicine
Naomi Herz
Josh Rising
Frederic S ResnicComparative Effectiveness Research Institute and Department of Cardiovascular Medicine, Lahey Clinic Foundation, USA Tufts University School of Medicine
  • 1 - 10

Datasets